ScreenerHero

FLUI Fluicell AB (publ)

STO · SE · Healthcare · Biotechnology · fluicell.com
29.20SEK-2.34%Mkt Cap: 3.84M $P/E: 14.38

Fluicell AB (publ), a life science company, develops and provides clay instruments for 3D bioprinting and cell analysis and flow control on single-cell level in Sweden. The company offers BIOPEN, a powerful tool for high…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$128.08BUSDP/E 29.4
MRNA
Moderna, Inc.
$78.44BUSD
REGN
Regeneron Pharmaceuticals, Inc.
$76.40BUSDP/E 18.4
ARGX
argenx SE
$57.03BUSDP/E 37.3
ARGX
argenx SE
$58.08BUSDP/E 35.4
UCB
UCB SA
$42.24BUSDP/E 18.0
RVMD
Revolution Medicines, Inc.
$43.05BUSD
ONC
BeOne Medicines AG
$41.41BUSDP/E 65.1
RPRX
Royalty Pharma plc
$32.80BUSDP/E 30.2
ALNY
Alnylam Pharmaceuticals, Inc.
$30.03BUSDP/E 37.8
ROIV
Roivant Sciences Ltd.
$25.10BUSD
BNTX
BioNTech SE
$23.93BUSD
INCY
Incyte Corporation
$22.99BUSDP/E 14.5
GMAB
Genmab A/S
$22.27BUSDP/E 30.7
GMAB
Genmab A/S
$22.54BUSDP/E 28.9
INSM
Insmed Incorporated
$22.22BUSD
ASND
Ascendis Pharma A/S
$15.03BUSDP/E 17.5
JAZZ
Jazz Pharmaceuticals plc
$15.01BUSDP/E 15.8
EXEL
Exelixis, Inc.
$14.48BUSDP/E 18.4
SMMT
Summit Therapeutics Inc.
$14.32BUSD

Key Statistics

Company
Market Cap3.84M USD
Enterprise Value4.12M USD
Revenue (TTM)1.76M USD
Gross Profit1.26M USD
Net Income (TTM)-796.97K USD
Revenue/Share13.42 SEK
Last Price29.20 SEK
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees11
CountrySE
SectorHealthcare
IndustryBiotechnology
ISINSE0010831321
Valuation
P/E (Trailing)14.38
P/E (Forward)—
PEG—
EV/EBITDA14.63
EV/Revenue2.33
P/S2.23
P/B2.49
EPS (TTM)2.03
EPS (Forward)—
52W Range
7.65036% of range67.20
52W High67.20 SEK
52W Low7.650 SEK
Profitability
Gross Margin218.79%
Oper. Margin30.77%
EBITDA Margin15.96%
Profit Margin-138.82%
ROE-76.43%
ROA-45.10%
Growth
Revenue Growth933.70%
Earnings Growth—
Cash Flow & Leverage
Operating CF-472.90K USD
CapEx (TTM)829.11K USD
FCF Margin-54.06%
FCF Yield-24.85%
Net Debt188.43K USD
Net Debt/EBITDA0.67
Balance Sheet
Debt/Equity12.14
Current Ratio1.40
Quick Ratio1.00
Book Value/Sh11.99 SEK
Cash/Share0.02 SEK
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 SEK
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:350
Split DateMar 26, 2025
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.1.37M
Float1.17M
Insiders21.15%
Institutions8.90%
Technical
SMA 5030.95 (-5.7%)
SMA 20023.24 (+25.6%)
Beta2.12
S&P 52W Chg16.45%
Avg Vol (30d)7.05K
Avg Vol (10d)3.08K
Technical Indicators
RSI (14)42.2
MACD-0.5825
MACD Signal-0.4720
MACD Hist.-0.1105
BB Upper33.71 SEK
BB Middle30.81 SEK
BB Lower27.91 SEK
BB Width18.85%
ATR (14)1.878 SEK
Vol Ratio (20d)0.50x